Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $87.7800 (-2.54%) ($87.7800 - $89.4000) on Fri. Sep. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.61% (three month average) | RSI | 30 | Latest Price | $87.7800(-2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(49%) IWO(49%) IWC(47%) IBB(45%) | Factors Impacting LGND price | LGND will decline at least -1.305% in a week (0% probabilities). UUP(-17%) VXX(-16%) TBT(-8%) UNG(-7%) VIXM(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.305% (StdDev 2.61%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.41(-4.98%) | Resistance Level | $95.23 | 5 Day Moving Average | $90.57(-3.08%) | 10 Day Moving Average | $92.11(-4.7%) | 20 Day Moving Average | $95.23(-7.82%) | To recent high | -18.5% | To recent low | 15.3% | Market Cap | $1.411b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |